Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
49%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
39%
ALSO IN MEDX
MEDX
27
HOLDINGS
33%
ALSO IN PPH
SECTOR DRIFT (PPH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 17.2% | 17.2% |
 |
NOVARTIS AG-ADR | 10.6% | 7.3% | 7.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.9% | 5.0% | 4.9% |
|
JOHNSON & JOHNSON | 4.7% | 5.6% | 4.7% |
|
ABBVIE INC | 4.0% | 8.3% | 4.0% |
PPH Overweight Relative to MEDX
|
MERCK & CO. INC. | 5.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.6% |
|
MCKESSON CORP | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
CENCORA INC | 3.9% |
|
NOVARTIS AG-ADR | 3.4% |
|
ZOETIS INC | 3.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.7% |
|
ELI LILLY & CO | 1.9% |
PPH Underweight Relative to MEDX
 |
ASTRAZENECA PLC | -5.3% |
|
IONIS PHARMACEUTICALS, INC. | -5.2% |
|
AMGEN INC | -4.4% |
|
ABBVIE INC | -4.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
 |
ALKERMES PLC | -3.9% |
|
BIOGEN IDEC INC | -3.0% |
|
REGENERON PHARMACEUTICALS | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.5% |
|
BEAM THERAPEUTICS, INC. | -1.2% |